GLP-1 Medication & Dose Nutrition Protocols

The 0.25 mg initiation dose is sub-therapeutic for blood sugar but immediately triggers delayed gastric emptying. Here is how to safeguard your muscle mass from Day 1.

The jump from 0.25 mg to 0.5 mg is where 65% of patients encounter their first severe nausea spike. Here is the clinical Chrono-Nutrition rescue roadmap.

At 1.0 mg, appetite suppression is profound. Up to 40% of total scale weight loss can be skeletal muscle unless protein intake is clinically guarded.

The maximum 2.0 mg dose provides intense appetite blunting. Your daily protocol must treat protein as non-negotiable medicine.

Wegovy 1.7 mg is the penultimate titration step where fat loss accelerates and gastric transit reaches maximal delay.

At the full 2.4 mg maintenance dose, appetite suppression is at its clinical zenith. FitFighter protects your skeletal muscle mass.

Tirzepatide activates both GIP and GLP-1 receptors, producing faster fat loss but requiring precise 5-day half-life chrono-nutrition.

7.5 mg is where metabolic weight loss reaches escape velocity. FitFighter ensures every pound lost is adipose tissue, not lean muscle.

At 10 mg, Tirzepatide provides immense appetite regulation. FitFighter acts as your digital dietitian to keep your muscle mass protected.

The maximum 15 mg dose delivers up to 22.5% body weight reduction. Without strict clinical protein adherence, 35%+ of that weight loss is skeletal muscle.